SCHEMBL16264142

SCHEMBL16264142

CCC(=O)N(CC(C)=O)CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.39
FFAR3 O14843 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 3/20 0.33
EYA2 O00167 1/20 0.33
APP P05067 1/20 0.33
ACE P12821 1/20 0.33
SLC15A2 Q16348 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CHRM2 P08172 1/20 0.32
ADRA2A P08913 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
DRD1 P21728 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
CYP2C19 P33261 1/20 0.32
ADRA1A P35348 1/20 0.32
DRD3 P35462 1/20 0.32
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6444629 0.91 FFAR3 (0.47) TDP1FFAR3ALDH1A1LMNAEYA2
SCHEMBL10042458 0.91 ALDH1A1 (0.47) TDP1FFAR3ALDH1A1LMNA
SCHEMBL8602002 0.88 FFAR3 (0.45) TDP1FFAR3ALDH1A1LMNAEYA2
SCHEMBL24331732 0.83 FFAR3 (0.42) TDP1FFAR3ALDH1A1LMNASLC15A2
SCHEMBL19903149 0.81 ALDH1A1 (0.43) TDP1FFAR3ALDH1A1LMNA
SCHEMBL16264141 0.81 LMNA (0.39) TDP1FFAR3ALDH1A1LMNAEYA2
SCHEMBL17690254 0.78 MGAM (0.44) TDP1ALDH1A1LMNATSHR
SCHEMBL7975927 0.78 TDP1 (0.38) TDP1FFAR3ALDH1A1LMNAEYA2
SCHEMBL5080836 0.77 CA12 (0.43) TDP1FFAR3ALDH1A1LMNAEYA2
SCHEMBL17664802 0.77 CA12 (0.43) TDP1ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230374076-A1 THE PREPARATION OF CERAMIDE CONJUGATES AND DERIVATIVES OF SPHINGOLIPID ANALOGUES KODE BIOTECH LIMITED (NZ) 2023-11-23 US disclosed
US-20140350217-A1 FUNCTIONAL LIPID CONSTRUCTS KODE BIOTECH LIMITED (NZ) 2014-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230374076-A1 THE PREPARATION OF CERAMIDE CONJUGATES AND DERIVATIVES OF SPHINGOLIPID ANALOGUES SGMS1, SGMS2, CERT1 TDP1 2954/4885FFAR3 1266/4885ALDH1A1 3130/4885
US-20140350217-A1 FUNCTIONAL LIPID CONSTRUCTS CETP, LCAT, SGMS1 TDP1 4580/4885FFAR3 377/4885ALDH1A1 2075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.